BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 21530100)

  • 1. ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer.
    McDonald MW; Lawson J; Garg MK; Quon H; Ridge JA; Saba N; Salama JK; Smith RV; Yeung AR; Yom SS; Beitler JJ;
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1292-8. PubMed ID: 21530100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
    Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
    Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In regard to "ACR appropriateness criteria of recurrent head-and-neck cancer after prior definitive radiation." (Int J Radiat Oncol Biol Phys 2011;80:1292-1298).
    Kubicek GJ; Heron DE; Ferris RL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1322-3; author reply 1315-6. PubMed ID: 22385721
    [No Abstract]   [Full Text] [Related]  

  • 6. Reirradiation after salvage surgery and microvascular free flap reconstruction for recurrent head and neck carcinoma.
    Suh JD; Kim BP; Abemayor E; Sercarz JA; Nabili V; Liu JH; Juillard GJ; Blackwell KE
    Otolaryngol Head Neck Surg; 2008 Dec; 139(6):781-6. PubMed ID: 19041503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
    Salama JK; Vokes EE; Chmura SJ; Milano MT; Kao J; Stenson KM; Witt ME; Haraf DJ
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):382-91. PubMed ID: 16213104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and selection criteria in the retreatment of head and neck cancers.
    May ME; Cash ED; Silverman CL; Redman RA; Perez CA; Wilson LD; Tennant PA; Bumpous JM; Dunlap NE
    Oral Oncol; 2019 Jan; 88():85-90. PubMed ID: 30616802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck.
    Vargo JA; Ferris RL; Ohr J; Clump DA; Davis KS; Duvvuri U; Kim S; Johnson JT; Bauman JE; Gibson MK; Branstetter BF; Heron DE
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):480-8. PubMed ID: 25680594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.
    McDonald MW; Zolali-Meybodi O; Lehnert SJ; Estabrook NC; Liu Y; Cohen-Gadol AA; Moore MG
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):808-819. PubMed ID: 27788954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
    De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
    J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria.
    Ward MC; Koyfman SA; Bakst RL; Margalit DN; Beadle BM; Beitler JJ; Chang SS; Cooper JS; Galloway TJ; Ridge JA; Robbins JR; Sacco AG; Tsai CJ; Yom SS; Siddiqui F
    Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):759-786. PubMed ID: 35398456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?
    Wong SJ; Machtay M; Li Y
    J Clin Oncol; 2006 Jun; 24(17):2653-8. PubMed ID: 16763279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review.
    Kao J; Garofalo MC; Milano MT; Chmura SJ; Citron JR; Haraf DJ
    Cancer Treat Rev; 2003 Feb; 29(1):21-30. PubMed ID: 12633577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
    Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer.
    Salama JK; Vokes EE
    Semin Oncol; 2008 Jun; 35(3):251-61. PubMed ID: 18544440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reirradiation in squamous cell head and neck cancer: recent developments and future directions.
    Langendijk JA; Bourhis J
    Curr Opin Oncol; 2007 May; 19(3):202-9. PubMed ID: 17414637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
    Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K
    J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
    Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.